Related Experiment Video

Updated: May 31, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Attenuated oncolytic measles virus strains as cancer therapeutics

P Msaouel1, I D Iankov, A Dispenzieri

  • 1Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Current Pharmaceutical Biotechnology
|July 12, 2011
PubMed

Insights

Attenuated measles virus vaccine strains show promise as oncolytic vectors, effectively targeting and destroying cancer cells. Research is exploring methods to enhance their efficacy and overcome immune responses for improved cancer treatment.

Area of Science:

  • * Oncolytic virotherapy
  • * Cancer research
  • * Vaccine development

Background:

  • * Attenuated measles virus vaccine strains, specifically the Edmonston-B (MV-Edm) lineage, demonstrate selective oncolytic activity.
  • * These viruses infect, replicate within, and lyse cancer cells with minimal impact on normal tissues.
  • * Preclinical success has driven the clinical translation of these oncolytic measles vaccine strains.

Purpose of the Study:

  • * To review preclinical data supporting the clinical use of oncolytic measles vaccine strains.
  • * To provide an overview of early clinical trial findings for this oncolytic platform.
  • * To discuss emerging strategies for enhancing oncolytic measles virus efficacy.

Main Methods:

  • * Review of preclinical studies on measles virus vaccine strains as oncolytic agents.
  • * Analysis of early-phase clinical trial data for oncolytic measles virus therapy.
  • * Exploration of novel strategies including immune modulation, combination therapies, and virus retargeting.

Main Results:

  • * Measles virus vaccine strains exhibit significant anti-tumor activity across various cancers.
  • * MV-Edm strains show selective cancer cell lysis with low toxicity to normal cells.
  • * Early clinical data indicate the potential of this oncolytic platform.

Conclusions:

  • * Oncolytic measles virus vaccine strains represent a viable and promising cancer therapy.
  • * Ongoing research focuses on optimizing efficacy through immune evasion, combination treatments, and improved delivery.
  • * Further development is crucial for maximizing the therapeutic potential of this oncolytic platform.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid07:24

Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid

Published on: May 25, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...